Background: Factorial Mendelian randomization is the use of genetic variants to answer questions about interactions. Although the approach has been used in applied investigations, little methodological advice is available on how to design or perform a factorial Mendelian randomization analysis. Previous analyses have employed a 2 × 2 approach, using dichotomized genetic scores to divide the population into 4 subgroups as in a factorial randomized trial.
Mendelian randomization is the use of genetic variants as proxies for interventions on risk factors to answer questions of cause and effect using observational data [1, 2] . Formally, Mendelian randomization can be viewed as instrumental variable (IV) analysis using genetic variants as IVs [3, 4] . Factorial Mendelian randomization is the use of genetic variants to answer questions about interactions. It does this by proposing a statistical model for the outcome as a function of the risk factors (or their genetic predictors) and a product term.
A statistical interaction is observed when the coefficient for the product term in the model is non-zero. A statistical interaction in the causal model for the outcome may represent a causal interaction, meaning that the effect of one risk factor on the outcome is dependent upon the value of the other risk factor [5, 6] . This may arise due to a functional or biological interaction, in which there is a mechanistic connection between the two risk factors in how they influence the outcome. However, a statistical interaction may also arise due to non-linearity in the effect of a risk factor, or due to effect modification, in which the effect of one risk factor varies in strata of the other. Hereafter, we take the word 'interaction' to mean a statistical interaction in the causal model for the outcome, without implying a functional interaction between the risk factors.
Factorial Mendelian randomization was proposed in the seminal paper on Mendelian randomization by Davey Smith and Ebrahim in 2003 [1] . The term is credited by the authors to Sheila Bird. However, the idea was not readily taken up in applied practice. The concept was raised again by Davey Smith and Hemani in a 2014 review [7] , who suggested that genetic predictors of obesity and alcohol consumption could be used to investigate the interaction between the two risk factors on risk of liver disease. This question was investigated for markers of liver function using data from the Copenhagen General Population Study in 2018 [8] ; no evidence for an interaction was found.
In parallel to this, the term factorial Mendelian randomization has been used for analyses employing genetic variants as proxies for pharmacological interventions. Ference et al. performed factorial Mendelian randomization to compare the effect of lowering low density lipoprotein (LDL) cholesterol levels on the risk of coronary heart disease (CHD) with two different LDLcholesterol lowering agents (ezetimibe and statin), and with a combination of both [9] . Genetic variants associated with LDL-cholesterol were identified in the NPC1L1 gene (proxies for ezetimibe), and the HMGCR gene (proxies for statins), and combined into separate gene scores. To mimic a 2 × 2 factorial randomized trial, the two gene scores were dichotomized to create a 2 × 2 contingency table. The gene scores were dichotomized at their median values so 4 that the numbers of participants were balanced across the four groups. Ference has conducted similar analyses for PCSK9 inhibitors and statins [10] , and for CETP inhibitors and statins [11] . A similar 2 × 2 approach was used in each case, as well as in the analysis of obesity and alcohol mentioned above [8] .
In this paper, we consider various aspects relating to the conceptualization, design, analysis and interpretation of a factorial Mendelian randomization investigation. First, we demonstrate the analogy between factorial Mendelian randomization and a factorial randomized trial, we make a connection with multivariable Mendelian randomization, and we describe two contexts in which factorial Mendelian randomization may have utility: for investigating interactions between risk factors, and for investigating interactions between pharmacological interventions on risk factors. We present simulated data demonstrating that the 2 × 2 approach to analysis, while being conceptually appealing, is inefficient for detecting interactions. The same conclusion is reached in an applied investigation considering interactions between body mass index (BMI) and alcohol consumption on blood pressure using data from UK Biobank. Finally, we discuss the implications of our work to applied factorial Mendelian randomization investigations.
Methods

Factorial randomized trials and Mendelian randomization
A factorial randomized trial allows for the simultaneous assessment of two or more treatments in a single study [12] . In its simplest form, a 2 × 2 factorial trial investigates the effect of two binary treatments A and B on a binary outcome Y . Participants are randomly allocated to one of four groups: to receive treatment A only; to receive treatment B only; to receive both treatments A and B; or to receive neither treatment A nor B. The analogy between Mendelian randomization and a randomized trial has been made many times [13, 14] , and the analogy between factorial Mendelian randomization and a factorial randomized trial has also been made previously in the context of multivariable Mendelian randomization ( Figure 1 , adapted from [15] ).
Multivariable Mendelian randomization was motivated by the problem that some genetic variants are associated with multiple risk factors, such that it is impossible to find genetic variants that are specifically associated with a particular risk factor [15] . For illustration, we assume there are two risk factors (X 1 and X 2 ), and fit a model for the outcome in terms of the Figure 1: Comparison of a factorial randomized clinical trial and a factorial Mendelian randomization investigation with a 2 × 2 approach (adapted from [15] ).
We assume that we have genetic variants G that satisfy the multivariable IV assumptions for risk factors X 1 and X 2 [15] . Specifically:
1. Each variant is associated with at least one of the risk factors.
2. Each risk factor is associated with at least one of the genetic variants.
3. Variants are not associated with confounders of the risk factor-outcome associations.
4.
Variants are not associated with the outcome conditional on the risk factors and confounders.
If we have at least two genetic variants that are valid multivariable IVs for X 1 and X 2 , then causal effects θ 1 and θ 2 can be estimated from the two-stage least squares method by first regressing the risk factors on the genetic variants, and then regressing the outcome on the fitted values of the risk factors from the first-stage regressions [16] . If summarized data on the genetic associations with the outcome (β Y ) and the risk factors (β X1 ,β X2 ) are available, then the same estimates can be obtained by weighted linear regression of the beta-coefficients with the intercept set to zero:
where weights are the reciprocals of variances of the gene-outcome associations se(β Y ) −2 [17] .
In the language of a factorial randomized trial, this is referred to as an analysis performed 'at the margins' [18] . Estimates represent the average direct effect of each of the risk factors [19] . If there is an interaction between the risk factors, then these are marginal estimatesthey are averaged over the distribution of the other risk factor. 6 We can extend multivariable Mendelian randomization by adding a term to the outcome model to estimate an interaction between the risk factors:
where X 12 is the product X 1 × X 2 , and θ 12 is the interaction effect on an additive scale. In a factorial randomized trial, this is referred to as an analysis performed 'inside the table', as in a 2 × 2 setting, the interaction can be estimated from the 2 × 2 contingency table [20] . A factorial Mendelian randomization analysis is primarily interested in assessing the presence of, and estimating the interaction effect θ 12 .
Two contexts: interactions between risk factors and interactions between interventions
Factorial Mendelian randomization study has been considered in two broad scenarios: a) to estimate interaction effects between risk factors by using genetic variants as predictors of the risk factors; and b) to identify interactions between interventions by using genetic variants as proxies for specific treatments. In the first case, the aim is to identify an interaction in the effect of two distinct risk factors on the outcome. In the second case, there may not even be two distinct risk factors (as in the example of two LDL-cholesterol lowering interventions discussed by Ference et al. [9] ), and the aim is to identify an interaction in the associations of the genetic variants with the outcome. In this case, an interaction is inferred between the interventions for which the genetic variants are proxies. We consider these two scenarios in turn.
Interactions between risk factors
The multivariable IV assumptions imply that there is no effect of the genetic variants on the outcome except potentially indirectly via one or both of the risk factors. We divide the genetic variants into three groups: G 1 contains variants that are associated with X 1 , G 2 contains variants that are associated with X 2 , and G c contains shared variants that are associated with X 1 and X 2 ( Figure 2 ). We can now perform two-stage least squares by first regressing the risk factors X 1 , X 2 , and the product X 12 on the genetic variants, and then regressing the outcome on the fitted values of these risk factors. This analysis treats X 12 as if it is a separate risk factor unrelated to X 1 and X 2 [21] . For the second-stage regression model to be identified, at 7 least three IVs are required, as three parameters are estimated, and all risk factors (X 1 , X 2 , X 12 ) must be associated with at least one IV.
Figure 2: Causal directed acyclic graph illustrating relationships between variables in a factorial
Mendelian randomization framework for two risk factors (X 1 and X 2 ). There are three sets of genetic variants: G 1 (affecting X 1 only), G 2 (affecting X 2 only) and G c (shared variants, affecting X 1 and X 2 ). X 12 represents the product X 1 × X 2 . The main effects of the risk factors X 1 and X 2 on the outcome Y are θ 1 and θ 2 , and the interaction effect of X 1 and X 2 on Y is θ 12 . U 1 and U 2 are sets of confounders.
If we assume that the risk factors X 1 and X 2 are linear in the genetic variants:
then an interaction between the risk factors means that the statistical model for the outcome includes cross-terms between the genetic variants (such as G 11 × G 21 ). This motivates the use of cross-terms between the genetic variants as separate IVs.
Simulation study 1: interactions between risk factors
To investigate the performance of methods for estimating interactions between risk factors, we conduct a simulation study. We assume there are 10 genetic variants that are associated with X 1 and 10 genetic variants that are associated with X 2 , and vary the number of shared variants that are associated with both X 1 and X 2 from 0 (20 distinct genetic variants, each associated with one risk factor) to 10 (all 10 genetic variants associated with both risk factors). All genetic variants are simulated as independent (i.e. not in linkage disequilibrium). We compare four Method 3. Continuous gene scores: We construct weighted gene scores for each risk factor using external weights, and take the two gene scores and their product as IVs.
Method 4. Dichotomized gene scores: We dichotomize both gene scores at their median, and take the two dichotomized gene scores and their product as IVs. This is equivalent to a 2 × 2 analysis.
The data-generating model for the simulation study is provided in the Supplementary Material. Data were generated 10 000 times for each set of parameters on 10 000 individuals.
Parameters were set such that the set of genetic variants explains around 10% of the variance in each risk factor. The effect of X 1 on the outcome was θ 1 = 0.3, the effect of X 2 on the outcome was θ 2 = 0.2, and the interaction effect of X 12 on the outcome took values θ 12 = 0.1, 0.3, and 0.5.
Simulation study 2: interactions between interventions
We performed a further simulation study to investigate methods for detecting interactions between interventions. We assume there are 3 independent genetic variants that are proxies for intervention A, and the same for intervention B. Fewer variants are considered here as typically variants for such an analysis will come from a single gene region for each risk factor [9] . We compare two approaches:
1. Continuous gene scores: We construct weighted gene scores for changes in the risk factor corresponding to each intervention using external weights, and take the two gene scores and their product as IVs 2. Dichotomized gene scores: We dichotomize both gene scores at their median, and take the two dichotomized gene scores and their product as IVs. This is equivalent to a 2 × 2 analysis.
In each case, we regressed the outcome on the IVs, and estimated an interaction term. As before, the data-generating model for the simulation study is provided in the Supplementary Material. Data were generated 10 000 times for each set of parameters on 10 000 individuals.
The interaction effect took values 0.1, 0.3, and 0.5. We varied the minor allele frequencies of the genetic variants used as proxies for interventions A and B, drawing from a uniform distribution between 0.1 and 0.2 (uncommon), or between 0.4 and 0.5 (common), and the proportion of variance explained by the genetic variants (3%, 5% or 7%).
Applied example: the effects of BMI and alcohol on systolic blood pressure Increased systolic blood pressure (SBP) is associated with a range of health conditions, including cardiovascular disease and diabetes [22, 23] . Whilst there have been numerous studies highlighting the adverse effects of increased BMI on SBP [24, 25] , and the adverse effects of increased alcohol consumption [26] , there has been little research on the combined effect of BMI and alcohol consumption on SBP. We illustrate factorial Mendelian randomization by performing an analysis using individual participant data from UK Biobank to estimate the interaction effect of BMI and alcohol consumption on SBP. UK Biobank is a prospective, populationbased cohort consisting of around 500,000 participants aged from 40 to 69 years at baseline living in the UK. For the analysis, we considered 291,781 unrelated participants of European descent who passed data quality control measures and had genetic data available.
We used the 77 genome-wide significant variants from a meta-analysis by the Genetic Investigation of ANthropometric Traits (GIANT) consortium in participants of European ancestry to act as IVs for BMI [27] . For alcohol, we identified 10 genetic variants in the ADH1B gene region that have been shown to be associated with alcohol consumption [28] .
We performed factorial Mendelian randomization analyses using the full set of interactions, continuous gene scores, and dichotomized gene scores. We also performed analyses separately using the lead variant from the ADH1B gene region (rs1229984) as the sole IV for alcohol consumption, as was done in the analysis by Carter et al. [8] .
Results
Simulation study 1: interactions between risk factors
Results from the simulation study for estimating interactions between risk factors are displayed in Table 1 (no shared variants) and was the least efficient. With shared variants, method 1 was the most efficient throughout, and its efficiency was not strongly affected by the risk factors having genetic predictors in common. Between methods 2 and 3, method 2 was more efficient when most of the variants were non-shared, whereas method 3 was more efficient when most of the variants were shared.
Again, method 4 was the least efficient in all scenarios. This suggests that the 2 × 2 approach may be underpowered in practice, and instead approaches using all genetic variants and their cross-terms should be considered.
We also varied the strength of the genetic variants due to potential concerns about weak instruments [29] . We considered scenarios in which the genetic variants explained 1% and 5% of variance in the risk factors. Although substantial weak instrument bias was observed for the main effects, no bias was observed for the interaction term, even when there were 100 IVs in the analysis and F-statistics and conditional F-statistics [30] for the product term were around 1 ( Supplementary Tables A2 and A3) . Similar findings were observed in a one-sample setting when varying the direction of confounder effects on the risk factor and outcome (results not shown). We also performed the simulation study centering the values of the risk factors to reduce the impact of collinearity. This changed the mean estimates of the main effects θ 1 and θ 2 and improved precision for the main effect estimates, but estimates and inferences for the interaction term θ 12 were unchanged ( Supplementary Table A1 ). These additional simulations
suggest that factorial Mendelian randomization should only be used when the interaction is the main object of interest, and numerical estimates for the main effects from this model should be interpreted with caution.
Results from the simulation study for estimating interactions between interventions are displayed in Table 3 . While the numerical values of estimates differed between the two approaches, a consistent finding was that power to detect an interaction was greater using continuous gene scores than using dichotomized gene scores. Varying the proportion of variance explained by the genetic variants had no discernable effect on the power to detect an interaction. This can be seen by comparing scenarios 1, 2, and 3, and scenarios 5 and 6. However, varying the minor allele frequency had a strong effect on power, with greater power when the minor allele frequency was close to 0.5. This can be seen by comparing scenarios 2, 4, and 5, and scenarios 3 and 6. This suggests that ensuring comparable size between subgroups is an important factor for efficient detection of interactions, and can be more important than ensuring that the strongest variant is used in the analysis. (Table 4 ). However, the difference in mean alcohol levels between subgroups was reduced when using the 10 variant score, as most of the difference is due to the rs1229984 variant.
Estimates of the interaction between BMI and alcohol consumption are displayed in Table 5 .
For the dichotomized gene scores, efficiency is greater when the rs1229984 variant is used, suggesting the importance of dichotomizing the risk factor at a natural break in its distribution (if one exists) rather than ensuring that subgroups are equal in size. However, efficiency is strikingly improved using the full set of interactions, with the standard error decreasing over ten-fold using the 10 variants, and by a factor of four using the rs1229984 variant, compared to the 2 × 2 analysis. All estimates are compatible with the null, suggesting a lack of interaction in the effects of BMI and alcohol on SBP. There was no evidence of weak instrument bias, even though up to 857 IVs were used in the analyses and F-statistics were generally low ( Supplementary Table A4 ).
Discussion
In this paper, we have provided a brief review of factorial Mendelian randomization, an approach that uses genetic variants as instrumental variables to detect interactions. We have described two broad scenarios in which factorial Mendelian randomization has been implemented: to explore interactions between risk factors, and to explore interactions between interventions. Although most (perhaps even all) factorial Mendelian randomization analyses have been conducted using a 2×2 approach in which the sample is divided into 4 subgroups, we have shown that this approach is generally inefficient, particularly for exploring interactions between risk factors. This has been demonstrated in simulation studies, and in an applied example in which a four-to ten-fold improvement in efficiency was observed by an analysis using the full set of interactions between the genetic variants as IVs.
Choice of variants
Our findings suggest that factorial Mendelian randomization analyses should be conducted using all available genetic variants that are valid instruments: that is, that satisfy the multivariable IV assumptions. Analyses should not only include the genetic variants as main effects, but also all relevant two-way cross-terms. If investigators want to perform a 2 × 2 analysis, this should be done to illustrate the method rather than being the main analysis for testing the presence of an interaction. For a 2 × 2 analysis, the primary consideration for choosing genetic variants should be to divide the population at a natural break in the distribution of the risk factor, in order to maximize the difference between the mean level of the risk factor in the two halves of the population. If there is no natural break in the distribution, then investigators should find a division that splits the population as far as possible into equal groups. This may entail selecting genetic variants that explain less variance in the risk factor, but have minor allele frequency closer to 50%. There can also be substantial benefit in including multiple variants in a single gene region in an analysis, even if these variants only explain a small additional proportion of variance in the risk factor.
Weak instrument bias and efficiency
Conventionally, it is discouraged to use large numbers of genetic variants that are not strongly associated with the risk factor in a Mendelian randomization analysis due to weak instrument bias [31] . Although we did not detect any bias from weak instruments on interaction terms in our simulations, we acknowledge that users of the method may be reluctant to use hundreds of cross-terms as IVs. We would therefore encourage the use of continuous gene score methods as sensitivity analyses. Such analyses estimate fewer parameters, so should be less susceptible to bias. However, this advice is precautionary; no evidence of weak instrument bias in interaction estimates was observed in our simulations.
Summarized data
While multivariable Mendelian randomization can be performed using summarized data that are typically reported from genome-wide association studies by large consortia, this is not possible for factorial Mendelian randomization. If summarized association estimates are available on genetic associations with the product of the two risk factors, as well as associations with the risk factors individually, then the interaction effect can in principle be estimated by weighted linear regression of the beta-coefficients as in multivariable Mendelian randomization. However, if association estimates are only available for genetic variants, then the regression model is not identified asymptotically due to collinearity, and finite-sample estimates will be biased [32] . Association estimates for some cross-terms of genetic variants are additionally required.
Hence, factorial Mendelian randomization can be performed using summarized data, but only if bespoke summarized data are available on associations of genetic variants and their cross-terms with the risk factors and their product.
Interpretation of the interaction effect
If genetic variants each satisfy the assumptions of an IV, then an interaction between risk factors has a causal interpretation. However, there is no way of distinguishing a purely statistical interaction from a mechanistic or biological interaction based on observational data. We therefore advise caution in the interpretation of interaction findings, as a statistical interaction can arise due to non-linearity in the effect of a risk factor, or because of the scale on which the outcome is measured (for example, an interaction may occur on the original scale, but not on a log-transformed scale). When considering an interaction between interventions, researchers can investigate whether there is an interaction between the interventions on the risk factor(s) as well as on the outcome. This may help reveal where any biological interaction may take place.
Comparison with previous work
Previous work investigating interactions using IVs has been limited. A formal framework for defining interaction effects in the context of clinical trials was proposed by Blackwell [33] , who used the language of principal stratification (compliance classes and monotonicity) to define local average interaction effects in a similar way to how local average causal effects (also called complier-averaged causal effects) are defined for single risk factors [34] . However, the principal stratification framework presupposes that risk factors are binary (or categorical)
to assign compliance classes, whereas risk factors in Mendelian randomization are typically continuous. Additionally, the principal stratification framework presupposes a single binary instrumental variable, whereas Mendelian randomization investigations often use multiple genetic variants. There is therefore little practical advice in the literature on how to perform a factorial Mendelian randomization analysis.
Limitations
There are several limitations to this work. We rely on the assumption that all genetic variants included in our analyses are valid IVs. If they are not, then estimates may be biased. Our recommendations rely on simulated data. Different choices for the parameters included in the simulation studies may have resulted in different conclusions. However, our findings were robust to different choices of parameters considered in this paper, they correspond to what we know about the theoretical properties of estimators, and similar conclusions were observed from the applied analysis. We have only considered interactions on an additive scale, although interactions could be considered on a multiplicative scale by log-transforming the outcome. Finally, we have not considered the impact of model misspecification on estimates.
It would not be possible to perform simulation studies corresponding to all possible ways that model misspecification could occur, meaning that our recommendations cannot be proven to be optimal in all settings. We believe that we have chosen parameters and scenarios that are relevant to modern Mendelian randomization analyses.
Conclusion
Overall, factorial Mendelian randomization is a promising technique for assessing interactions using genetic variants as instrumental variables. Our findings suggest that current applications of factorial Mendelian randomization based on a 2 × 2 analysis could be improved by better 
Supplementary Material
In the Supplementary Material, we provide more detail on the two simulation studies and the applied example presented in the paper.
Simulation study 1: interactions between risk factors
The two risk factors X 1 and X 2 were generated for i = 1, 2, . . . , 10 000 participants from the following data-generating model:
where G 1 and G 2 are the genetic variants associated with X 1 and X 2 respectively, and G c are the set of shared variants that are associated with both X 1 and X 2 (bold font represents vectors). The genotypes (0, 1 or 2) were generated independently from binomial distributions Bin(2, M AF j ), where M AF j represents the minor allele frequency (MAF) of the j th genetic variant, and was drawn from a uniform distribution Unif(0.1, 0.5). α 1 and α 1c represent the effects of the genetic variants G 1 and G c on X 1 , and α 2 and α 2c represent the effects of the genetic variants G 2 and G c on X 2 . The genetic associations were calculated so that G 1 and G c , and G 2 and G c , explained σ 2 1 = σ 2 2 = 10% of the variance in X 1 and X 2 respectively. To ensure that each genetic variant explained the same amount of variation in the risk factor, we rearranged:
to calculate the genetic associations:
. U 1 and U 2 represent the set of confounding variables of the X 1 − Y and X 2 − Y associations. To ensure the confounders explained 25% of the variation in the risk factors, U 1 and U 2 were drawn independently from a normal distribution N (0, 0.25). To fix the variances of X 1 and X 2 to one, the error terms 1 and 2 were generated independently from a normal distribution A1 with mean zero, and variance:
The outcome Y was generated from:
where θ 1 and θ 2 represent the main effects of X 1 and X 2 on Y , and θ 12 represents the interaction effect of X 1 and X 2 on Y . X 12 was generated by either: a) multiplying X 1 and X 2 ; or b) multiplying the mean centred values of the risk factors (X 1 −X 1 ) and (X 2 −X 2 ), wherē X 1 andX 2 are the mean values of X 1 and X 2 . To ensure the risk factors and confounders explained less than a third of the variance in the outcome, the error term Y was generated from a standard normal distribution N (0, 1). Two-stage least squares regression models were fitted to either: a) the directly generated values of the risk factors (X 1 , X 2 , X 12 = X 1 × X 2 ); or b) the mean centred values of the risk factors (X 1 −X 1 , X 2 −X 2 , X 12 = (X 1 −X 1 ) × (X 2 −X 2 )). When the risk factors were mean centred, the model estimated the marginal effects θ 1M and θ 2M of X 1 and X 2 on Y , otherwise θ 1 and θ 2 were estimated. For example, when there were no shared variants J c = 0, the marginal effects were approximately:
The genetic variants were either treated as individual IVs or as a single instrument in externally weighted gene scores GS X 1 and GS X 2 for X 1 and X 2 . The external weights for the gene scores were based on an independent set of 10 000 individuals, and were produced from the same data generating model used for the main set of participants. The following four sets of genetic variants were used as IVs in separate two-stage least squares regression models:
• Method 1 -full set of interactions: the J 1 , J 2 and J c genetic variants used to generate X 1 and X 2 , plus the unique interactions and quadratic terms of (G 1 + G c ) × (G 2 + G c ).
• Method 2 -reduced set of interactions: the J 1 , J 2 and J c genetic variants used to generate X 1 and X 2 , plus the interactions from the product G 1 × G 2 .
• Method 3 -continuous gene scores: the two weighted gene scores GS X 1 and GS X 2 , and their product GS X 1 × GS X 2 .
• Method 4 -dichotomized gene scores: the two dichotomized gene scores, and their product.
Method 1 represents the oracle model as it includes all of the variables used in the data generating model, whereas Methods 2 to 4 are misspecified and their performance should be compared to Method 1. In Method 2, we have included a subset of the cross-terms between the genetic variants to create a more realistic scenario where the full set of relevant IVs are not included in the analysis. Method 3 considers the impact of including all of the genetic variants into two separate weighted gene scores, and finally, Method 4 considers the impact of dichotomizing the weighted gene scores. Supplementary Table A3 : Simulation study results for interactions between risk factors varying the amount of variance in the risk factors explained by the genetic variants, with 5 shared variants and an interaction effect θ 12 = 0.3: mean F-statistic (F-stat), mean conditional Fstatistic (CF-stat), median estimate, standard deviation (SD) of estimates, median standard error (SE), empirical power (%) to reject null at 5% significance, and coverage (%) of 95% confidence interval. A6
Simulation study 2: interactions between interventions
Using the same notation defined in the first simulation study, the risk factor X was generated for i = 1, 2, . . . , 10 000 participants from the following data generating model:
We assume that the two gene regions are distinct, and the genetic variants G A and G B are not in linkage disequilibrium. The genotypes were generated independently from binomial distributions Bin(2, M AF j ), where M AF j represents the MAF for the j th genetic variant. M AF j was drawn from a uniform distribution U(M AF L , M AF U ), where the value of M AF L and M AF U were either taken as 0.4 and 0.5 (common variants), or 0.1 and 0.2 (uncommon variants). We assumed that the interaction effect α AB was constant across the J A × J B product terms for simplicity. The approximate proportion of variance explained in X by G A (σ 2 A ) and G B (σ 2 B ) varied between scenarios. As before, the genetic associations α A and α B were calculated by rearranging the formula for the variance of the genetic variants to ensure the amount of variance explained by each variant was the same:
.
The confounders U were drawn from N (0, 0.25), and the error term X was generated from N (0, 0.65). The outcome Y was generated from:
where θ 1 represents the causal effect of X on Y , and the error term Y was generated from a standard normal distribution N (0, 1). The data was generated 10 000 times under the following scenarios:
• 2), σ 2 A = 3% and σ 2 B = 7% with J A = J B = 3, θ 0 = 0.2, θ 1 = 0.1, and α AB = 0.1, 0.3 and 0.5. The above scenarios were selected to consider the impact of varying the MAF and the amount of variance in the risk factor explained by the genetic variants had on the performance of the method.
For each scenario, optimal weighted gene scores GS A and GS B were generated for each gene region, where the external weights were produced from an independent set of 10 000
